The CEO of Northfield-based Medline cheered the company’s successful initial public offering late last year while discussing how tariffs have taken a bite out of its profits, in an interview with the ...

Medline (MDLN) has caught investors’ attention after a 4.39% decline over the past day, contrasted with gains of 1.27% over the week and 11.77% over the past month. These moves have put recent price ...

NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, ...

“Medline’s IPO was the largest private equity-backed IPO of all time, the largest healthcare IPO ever and the largest public offering of 2025, having traded up strongly on debut,” Robert Schmidt, ...

Jan 12 (Reuters) - Brokerages began coverage of Medline (MDLN.O), opens new tab with largely bullish ratings on Monday, betting on supply chain strength and brand penetration, following the firm's ...

Blood sugar tests help manage diabetes by monitoring glucose levels in the blood. High blood sugar can cause symptoms like thirst, blurry vision, and fatigue. Over time, too much glucose can damage ...

Medline has struck a series of new and expanded partnerships with health systems in recent months, reinforcing its position as a major supply chain player in both medical-surgical and laboratory ...

Medline CEO Jim Boyle (R) celebrates after ringing the opening bell at Nasdaq Marketsite headquarters on Dec. 17, 2025. Photo by Michael M. Santiago/Getty Images A blockbuster IPO from an ...

Medline Inc. completed a record-setting $6.26B IPO, allocating proceeds primarily to reduce leveraged buyout debt from 2021. MDLN operates globally with $20.6B YTD revenue, stable 10% growth, and ...

Medline completed a highly successful IPO, now trading at a $83 billion valuation, being granted a demanding 39x earnings multiple. Medline generates $25.5 billion in annual revenue, up 10% ...